دواء أولي (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "دواء أولي" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
2nd place
5th place
1st place
1st place
3rd place
8th place
11th place
86th place
low place
low place

books.google.com

doi.org

  • Rautio J, Meanwell NA, Di L, Hageman MJ (Aug 2018). "The expanding role of prodrugs in contemporary drug design and development". Nature Reviews. Drug Discovery (بالإنجليزية). 17 (8): 559–587. DOI:10.1038/nrd.2018.46. PMID:29700501.
  • Malhotra B، Gandelman K، Sachse R، Wood N، Michel MC (2009). "The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine". Current Medicinal Chemistry. ج. 16 ع. 33: 4481–9. DOI:10.2174/092986709789712835. PMID:19835561.
  • Stella VJ، Charman WN، Naringrekar VH (مايو 1985). "Prodrugs. Do they have advantages in clinical practice?". Drugs. ج. 29 ع. 5: 455–73. DOI:10.2165/00003495-198529050-00002. PMID:3891303. مؤرشف من الأصل في 2020-06-09.
  • Sneader W (2000). "The discovery of aspirin: a reappraisal". BMJ. ج. 321 ع. 7276: 1591–4. DOI:10.1136/bmj.321.7276.1591. PMC:1119266. PMID:11124191.
  • Wu KM (أكتوبر 2009). "A New Classification of Prodrugs: Regulatory Perspectives". Pharmaceuticals. ج. 2 ع. 3: 77–81. DOI:10.3390/ph2030077. PMC:3978533. PMID:27713225.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Rautio J, Meanwell NA, Di L, Hageman MJ (Aug 2018). "The expanding role of prodrugs in contemporary drug design and development". Nature Reviews. Drug Discovery (بالإنجليزية). 17 (8): 559–587. DOI:10.1038/nrd.2018.46. PMID:29700501.
  • Malhotra B، Gandelman K، Sachse R، Wood N، Michel MC (2009). "The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine". Current Medicinal Chemistry. ج. 16 ع. 33: 4481–9. DOI:10.2174/092986709789712835. PMID:19835561.
  • Stella VJ، Charman WN، Naringrekar VH (مايو 1985). "Prodrugs. Do they have advantages in clinical practice?". Drugs. ج. 29 ع. 5: 455–73. DOI:10.2165/00003495-198529050-00002. PMID:3891303. مؤرشف من الأصل في 2020-06-09.
  • Sneader W (2000). "The discovery of aspirin: a reappraisal". BMJ. ج. 321 ع. 7276: 1591–4. DOI:10.1136/bmj.321.7276.1591. PMC:1119266. PMID:11124191.
  • Wu KM (أكتوبر 2009). "A New Classification of Prodrugs: Regulatory Perspectives". Pharmaceuticals. ج. 2 ع. 3: 77–81. DOI:10.3390/ph2030077. PMC:3978533. PMID:27713225.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)

ncbi.nlm.nih.gov

semanticscholar.org

ukmi.nhs.uk

web.archive.org